Athletigen Technologies Inc. has recently announced a new global partnership with California’s Affymetrix Inc.

The Halifax startup investigates athletes’ potential through DNA analysis, and hopes to reach future Olympians and other high-level professional athletes as a result of the recent partnership.

Athletigen will now be able to incorporate the Affymetrix Axiom genotyping platform into its analyses.

According to Athletigen’s CEO Dr. Jeremy Koenig (BSc’03, PhD’09), the partnership will allow the startup to “accelerate discovery,” as they will now be able to analyze hundreds of thousands of athletic performance variables through saliva samples.

Dr. Koenig explains that this capacity will allow Athletigen to provide athletes with more information and suggestions of areas to target in training, including areas such as nutrition, athleticism and sports psychology.

Read more in “Partnership to benefit athletes” on thechronicleherald.ca.